abstract |
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R<1>, R<2>, R<3A>, R<3B>, R<4>, R<5>, R<6>, R<7>, R<8>, and X are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, and intermediates are also disclosed. |